|
POLR3C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.207200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.706800E-01 |
| Normal-vs-Stage2 |
8.767800E-02 |
| Normal-vs-Stage3 |
2.904000E-01 |
| Normal-vs-Stage4 |
3.033800E-01 |
| Stage1-vs-Stage2 |
6.899700E-02 |
| Stage1-vs-Stage3 |
2.203400E-01 |
| Stage1-vs-Stage4 |
2.088800E-01 |
| Stage2-vs-Stage3 |
1.439650E-02 |
| Stage2-vs-Stage4 |
3.098300E-02 |
| Stage3-vs-Stage4 |
7.523400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.050200E-01 |
| Normal-vs-AfricanAmerican |
1.715560E-01 |
| Normal-vs-Asian |
3.946200E-01 |
| Caucasian-vs-AfricanAmerican |
3.569600E-01 |
| Caucasian-vs-Asian |
7.732600E-01 |
| AfricanAmerican-vs-Asian |
5.000400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.442600E-01 |
| Normal-vs-Female |
8.877600E-01 |
| Male-vs-Female |
7.971000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.885000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.985800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.271000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.745000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.595800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.419200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.537960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.417200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.365800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.939400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.356200E-01 |
| Classical-VS-Follicular |
4.44089209850063E-16 |
| Classical-VS-Other |
8.369900E-02 |
| Classical-VS-Normal |
1.880160E-02 |
| Tall-VS-Follicular |
5.85959999965802E-07 |
| Tall-VS-Other |
8.404400E-02 |
| Tall-VS-Normal |
8.198100E-02 |
| Follicular-VS-Other |
3.335400E-01 |
| Follicular-VS-Normal |
6.20989999977617E-07 |
| Other-VS-Normal |
4.331400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.460630E-01 |
| Normal-vs-N1 |
9.538000E-01 |
| N0-vs-N1 |
3.282800E-01 |
|
|
